Mayo Clinic Nephrology, Hypertension and Kidney Transplantation Update for the Clinician 2024 C3G

Mayo Clinic Nephrology, Hypertension and Kidney Transplantation Update for the Clinician 2024

Efficacy of 12-week pegcetacoplan in kidney transplant recipients with recurrent C3 glomerulopathy (C3G) or immune complex membranoproliferative glomerulonephritis (IC-MPGN)

Access Resources

Back to Conference Resources

IG-MPGN and C3G Congress Presentations

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.

Mayo Clinic Nephrology, Hypertension and Kidney Transplantation Update for the Clinician 2024

Back to Conference Resources

Report an Adverse Event or Product complaint

Ask a Medical Question

Connect with an MSL

Landing